|
Session 214: Oncology and Drug Discovery |
|
|
Day 3: Morning, July. 17, 2022 |
|
|
Chair |
Dr. Alexander Nirenberg, Director, Australasian College of Cutaneous Oncology, Australia |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-08:55 |
Title: Striking Features and Complex Regulation of Polyketide Antibiotic Auricin from Streptomyces lavendulae subsp. lavendulae CCM 3239 Dr. Jan Kormanec, Institute of Molecular Biology, Slovak Academy of Sciences, Slovak |
|
08:55-09:15 |
Title: From Non-Genomic to Genomic Research Dr. Mehrdad Ghashghaeinia, Professor, University Medical Center Schleswig-Holstein, Germany |
|
09:15-09:35 |
Title: Cytotoxic Effect of Houttuynia Cordata Thunb. Hexane Fraction on Human Breast Cancer Regulated Cell Death via Intrinsic and Extrinsic Pathways, ER and Oxidative Stresses and Ameliorated Cell Survival Signaling Dr. Ratana Banjerdpongchai, Associate Professor, Chiang Mai Univeristy, Thailand |
|
09:35-09:55 |
Speech Opportunity Available |
|
09:55-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:50 |
Title: MultiOmyx Technology and Its Use in the Drug Discovery Process Dr. Anna Juncker-Jensen, Senior Scientist, NeoGenomics Laboratories, USA |
|
10:50-11:10 |
Title: A Novel Drug Screening Method Identified Molecules Targeting the Pro-oncogenic Properties of the Telomeric Protein TRF2 Dr. Julien Cherfils Vicini, Researcher, IRCAN INSERM, France |
|
11:10-11:30 |
Title: TBD Dr. Yuichiro Asai, Research Associate, Department of Chemistry and Biochemistry, School of Advanced Science and Engineering, Waseda University, Japan |
|
11:30-11:50 |
Title: Transformed Astrocytes in Culture as a Model for Glioma Treatment Dr. Italia Di Liegro, Professor, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Italy |
| 11:50-12:10 |
Title: Epigenetic Therapeutics and Embryonal Tumors Dr. Floriana Bulic-Jakus, Professor, University of Zagreb, Croatia |
|
Session 224: Emerging Drug Screening Technology |
|
|
Day 3: Morning, July. 17, 2022 |
|
|
Chair |
Dr. Shanavaz Nasarabadi, President & Director R&D, GenTegra LLC, USA |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Title: Innovative Biochip Platform with Unparalleled Sensitivity and Reproducibility, Applicable in both Drug screening/Optimization and (Cancer) Diagnostics Dr. Henk Leeuwis, Vice President Strategy and Innovation, LioniX International, the Netherlands |
|
09:25-09:50 |
Title: Label-free Readout in 1536 Format with MALDI-TOF Mass-spectrometry Dr. Steven van Helden, Chief Technology Officer, Pivot Park Screening Centre B.V., Netherlands |
|
09:50-10:15 |
Title: Patient Centric Microsampling Dr. Shanavaz Nasarabadi, President & Director R&D, GenTegra LLC, USA |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Title: Smart Gelatin - Collagen Matrixes with Integrated Bio-optical Sensors for the Monitoring of Cancer Cell Metabolism during Treatment Dr. Boudewijn van der Sanden, Researcher, INSERM, France |
|
Session 314: Emerging Drug Targets for Metabolic Disorders |
|
|
Day 3: Morning, July. 17, 2022 |
|
|
Chair |
Dr. Maximilian Dirnbacher, CEO, cellumina GmbH, Austria |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Title: Targeting the Inositol Pyrophosphate Pathway in Metabolic Diseases Dr. Anutosh Chakraborty, Associate Professor, Department of Pharmacology and Physiology, Saint Louis University School of Medicine, USA |
|
09:25-09:50 |
Title: Observation and Characterization of Microvascular Vasomotion and its Relationship to Edema Using ICG-loaded Erythrocyte Angiography Dr. Maximilian Dirnbacher, CEO, cellumina GmbH, Austria |
|
09:50-10:15 |
Title: Therapeutic Effect of Integrin-linked Kinase Gene-modified Bone Marrow-derived Mesenchymal Stem Cells for Streptozotocin-induced Diabetic Cystopathy in a Rat Model Dr. Liucheng Ding, Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, China |
|
10:15-10:30 |
Coffee Break |
| 10:30-10:55 |
Title: TBD Dr. Patricia McDonald, Associate Professor, Associate Member, Cancer Physiology, Moffitt Cancer Center, USA |
| 10:55-11:20 |
Title: TBD Dr. Zeinab A. El-Kabbany, Professor, Pediatrics Department, Faculty of Medicine, Ain Shams University, Egypt |
| 11:20-11:45 |
Speech Opportunity Available |
| 11:45-12:10 |
Speech Opportunity Available |
|
Session 324: Kinase Inhibitor Chemistry |
|
|
Day 3: Morning, July. 17, 2022 |
|
|
Chair |
Dr. Eduard Stefan, Head, Institute of Biochemistry, University of Innsbruck, Austria |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Title: Impact of mutation-specific kinase inhibitors on BRAF conformations & RAS interactions Dr. Eduard Stefan, Head, Institute of Biochemistry, University of Innsbruck, Austria |
|
09:25-09:50 |
Title: Impact of mutation-specific kinase inhibitors on BRAF conformations & RAS interactions Dr. Naoyuki Nishiya, Professor, Iwate Medical University School of Pharmacy, Japan |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
Session 416: Inflammation and Immunological Diseases |
|
|
Day 3: Morning, July. 17, 2022 |
|
|
Chair |
Dr. Yaakov Naparstek, Professor of Medicine, Department of Medicine, Hadassah University Hospital, Israel |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: Interstitial Cystitis: A Little Known Disease that Affects 10 Million People in the United States Dr. Vicki Ratner, Founder and President Emeritus, Interstitial Cystitis Association of America, USA |
|
09:00-09:25 |
Title: The use of liposomal corticosteroids in autoimmune inflammatory diseases Dr. Yaakov Naparstek, Professor of Medicine, Department of Medicine, Hadassah University Hospital, Israel |
|
09:25-09:50 |
Title: Oxidized Phospholipids in Inflammation: New Properties and Therapeutic Potential Dr. Konstantin Birukov, Professor, Department of Anesthesiology, University of Maryland School of Medicine, USA |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Title: Microtubules in Control of Lung Vascular Permeability and Nflammation Dr. Anna Birukova, Associate Professor, Section of Pulmonary/Critical Care, Department of Medicine, University of Chicago, USA |
|
10:55-11:20 |
Title: Protective Effects of Borago Officinalis (Borago) on Cold Restraint Stress-induced Gastric Ulcers in Rats Dr. Alessandro Di Cerbo, Researcher, University of Camerino, Italy |
|
11:20-11:45 |
Title: The Potential Roles of circRNAs in Osteoarthritis Dr. Shuying Shen, Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital Medical College of Zhejiang University, China |
|
11:45-12:10 |
Title: Ulcerative Sarcoidosis Successfully Treated with Infliximab Dr. Aleksandra Bukiej, Rheumatologist, Department of Internal Medicine, Division of Rheumatology, Rush University Medical Center, USA |
|
Session 417: Digestive System Diseases |
|
|
Day 3: Morning, July. 17, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Title: TBD Dr. Irina Trubitsyna, Head of the Laboratory, Russia Central Scientific Research Institute of Gastroenterology, Russia |
|
09:25-09:50 |
Title: TBD Dr. Yoshio Sumida, Associate Professor, Division of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University, Japan |
|
09:50-10:15 |
Title: TBD Dr. Mazen Noureddin, Director of Fatty Liver Program, Cedars-Sinai Medical Center, USA |
|
10:15-10:30 |
Coffee Break |
|
Session 418: Orphan and Rare Diseases |
|
|
Day 3: Morning, July. 17, 2022 |
|
|
Chair |
Dr. Dorianna Sandono, Professor, University of Padova, Italy |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: Challenges in Carrying out a Randomised Clinical Trial in Rare Diseases Dr. Lakshminarayan R. Ranganath, Professor, University of Liverpool, UK |
|
09:00-09:25 |
Title: Angelman Syndrome: Bedside, Bench and Beyond Dr. Lynne M. Bird, Professor, Department of Pediatrics, University of California, San Diego, USA |
|
09:25-09:50 |
Title: Emerging Therapeutic Strategies for Sarcoglycanopathy Dr. Dorianna Sandono, Professor, University of Padova, Italy |
|
09:50-10:15 |
Title: Effect of tt-farnesol and Myricetin on in Vitro Biofilm Formed by Streptococcus Mutans and Candida Albicans Dr. Marlise I Klein Furlan, Researcher, Sao Paulo State University (Unesp), School of Dentistry, Brazil |
|
10:15-10:30 |
Coffee Break |
| 10:30-10:55 | Speech Opportunity Available Abstract and Biography: Submit Here |
| 10:55-11:20 |
Title: Developing a Diagnostic Test for Growth Hormone Deficiency (GHD): Pharmacokinetics and Pharmacodynamics of Macimorelin (AEZS-130) in Healthy Adults Dr. Nicola Ammer, Vice President, Clinical Development and Chief Medical Officer, AEterna Zentaris Inc., Germany |
| 11:20-11:45 | Title: Treatments of Chronic Pelvic Pain
Dr. Sabine Sator-Katzenschlager, Professor & Vice Chair of Special anaesthesia and Pain medicine, Medical University of Vienna, Austria |
| 11:45-12:10 | Title: Asymptomatic Leishmania Infection in Humans
Dr. Manoel Sebastiao da Costa Lima Junior, Researcher, Department of Medicine, Universidade Federal da Grande Dourados, Brazil |
Session 423: Catch the New Wave of Protein and Peptide Therapy Day 3: Morning, July. 17, 2022 Chair Dr. Immanuel Lerner, Chief Executive Officer, Pepticom LTD, Isreal Time 13:30-13:35 Chair's Introduction 13:35-14:00 Title: A PD-L1 Affimer® Fc Antagonist, Production and Efficacy in Combination with a Small Molecule Activator of the Innate Immune System Dr. Amrik Basran, CSO, Avacta Life Sciences, UK 14:00-14:25 Title: Application of Artificial Intelligence in Peptide Drug Discovery: Opportunities and Challenges Dr. Immanuel Lerner, Chief Executive Officer, Pepticom LTD, Isreal 14:25-14:50 Title: Photoswitchable Diarylethene-modified Peptides: Promising Drug Candidates for Photopharmacology Dr. Igor Volodymyrovych Komarov, Professor and a Head of Supramolecular Chemistry Department, Taras Shevchenko National University of Kyiv, Germany 14:50-15:15 Speech Opportunity Available 15:15-15:30 Coffee Break 15:30-15:55 Title: Endoplasmatic Reticulum Shaping by Generic Mechanisms and Protein-induced Spontaneous Curvature Dr. Erich Sackmann, Professor, Physics Department, Technical University of Munich, Germany 15:55-16:20 Speech Opportunity Available 16:20-16:45 Title: TBD Dr. Toshifumi Akizawa, CEO, O-Force Co. Ltd, Japan 16:45-17:10 Speech Opportunity Available
Co-Chair
Dr. Igor Volodymyrovych Komarov, Professor and a Head of Supramolecular Chemistry Department, Taras Shevchenko National University of Kyiv, Germany
Abstract and Biography: Submit Here
Abstract and Biography: Submit Here
Abstract and Biography: Submit Here
|
Session 431: Natural Product Discovery |
|
|
Day 3: Morning, July. 17, 2022 |
|
|
Chair |
Dulcie A Mulholland, Professor of Organic Chemistry, University of Surrey, UK |
|
Co-chair |
Dr. Ildikó Bácskay, Associate Professor, Faculty of Pharmacy, University of Debrecen, Hungary |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Keynote speech Title: Bioactivity and Potential Therapeutic Benefits of Rhodomyrtone and Rhodomyrtus Tomentosa Leaf Extracts Dr. Supayang Voravuthikunchai, Director of Natural Product Research Center of Excellence, Prince of Songkla University, Thailand |
|
09:00-09:25 |
Title: The Use of Homoisoflavonoids in the Treatment of Retinopathy
Dr. Dulcie A Mulholland, Professor of Organic Chemistry, University of Surrey, UK |
|
09:25-09:50 |
Title: Natural Phenolic Polyether from Medicinal Plants of Boraginaceae Family, its Synthetic Analogues and their Comparative Anticancer Efficacy Dr. Vakhtang Barbakadze, Head of Laboratory of Plant Biopolymers, Tbilisi State Medical University, USA |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Title: Formulation Strategies in the Personalized Medication Dr. Ildikó Bácskay, Associate Professor, Faculty of Pharmacy, University of Debrecen, Hungary |
|
10:55-11:20 |
Title: Insect Associated Microbes as a Source for Drug Discovery Dr. Andreas Vilcinskas, Professor, LOEWE Center for Insect Biotechnology & Bioresources, Germany |
|
11:20-11:45 |
Title: Natural Marine Products in the Brazilian Amazon and Their Biotechnological Applications Dr. Rainiomar Raimundo Fonseca, Professor, University of the State of Amazonas, Brazil |
|
11:45-12:10 |
Title: Different Polymers and Natural Oils as Excipients of Simvastatin Matrix-type Transdermal Patch Dr. Erna C. Arollado, Director, Institute of Pharmaceutical Sciences, University of the Philippines Manila, Philippines |
|
Session 215: Innovations in Neuroscience Drug Discovery |
|
|
Day 3: Afternoon, July. 17, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Title: Neuroendocrinology of Male Sexual Behavior Dr. Elaine M. Hull, Professor, Department of Psychology, Program in Neuroscience, Florida State University, USA |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Title: TBD Dr. Dario Furnari, Professor, Department of Neuroscience, University of Exeter, UK |
|
15:15-15:30 |
Coffee Break |
| 15:30-15:55 |
Title: Controlled Drug Delivery to the Brain via BBB: New Opportunities Dr. Naum Goldstein, Research Director, BBU Pharmaceuticals Ltd, Russia |
| 15:55-16:20 |
Title: TBD Dr. Manuela G. Lopez, Professor, Director, Institute Teofilo Hernando for Drug Discovery, Universidad Autonoma de Madrid, Spain |
| 16:20-16:45 |
Title: Incorporation of Upper Motor Neurons in Preclinical Assays, Especially for Diseases of the Motor Neuron Circuitry Dr. P. Hande Ozdinler, Associate Professor, Northwestern University, USA |
| 16:45-17:10 |
Title: PET Imaging Probes for Brain Research and Drug Discovery. Dr. Changning Wang, Assistant Professor, Massachusetts General Hospital, USA |
|
Session 225: Computer-aided Drug Discovery |
|
|
Day 3: Afternoon, July. 17, 2022 |
|
|
Chair
|
Dr. Carlo A. Trugenberger, Founder and CEO, InfoCodex Semantic Technologies AG, Switzerland
|
|
Co-chair
|
Dr. Csaba Hetenyi, Associate Professor, University of Pecs, Hungary |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: The Use of Artificial Intelligence and Machine learning for Drug Discovery from Big Data on a GPU Platform Dr. Graham R. Ball, Professor, The John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, UK |
|
14:00-14:25 |
Title: Drug Discovery by Semantic Machine Intelligence: Methods and Concrete Successes Dr. Carlo A. Trugenberger, Founder and CEO, InfoCodex Semantic Technologies AG, Switzerland |
|
14:25-14:50 |
Title: New Mechanistic and Structural Features of the IL-15 System through Experimental Observations and Molecular Dynamics Simulations Dr. Jean-Yves Le Questel, Professor, University of Nantes, France |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:55 |
Title: Optimization of Drug-target Interactions using Fast Quantum Mechanical Protocols Dr. Csaba Hetenyi, Associate Professor, University of Pecs, Hungary |
|
15:55-16:20 |
Title: Structural Elucidation of Ligand Binding Mechanisms to Somatostatin Receptors Dr. Rita Börzsei, Senior Lecturer, University of Pecs, Hungary |
|
16:20-16:45 |
Title: Details of ABCG2 Multidrug Transporter Function Revealed by Molecular Dynamics Dr. Tamas Hegedus, Senior Research Fellow, HSemmelweis University, Hungary |
|
16:45-17:10 |
Title: Can Digital Technology Advance the Development of Treatments for Alzheimer's Disease? Dr. Marie Mc Carthy, Senior Director of Product Innovation, ICON Plc, Ireland |
|
Session 325: New Small Molecule Drug Discovery |
|
|
Day 3: Afternoon, July. 17, 2022 |
|
|
Chair |
Dr. Masha Poyurovsky, Vice President, Kadmon Corporation, LLC, USA |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Title: Targeting ROCK in Fibrotic Disease Dr. Masha Poyurovsky, Vice President, Kadmon Corporation, LLC, USA |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Title: Development of Dinitrosyl Iron Complexes for Controlled Delivery of Nitric Oxide and NO-related Biomedical Application Dr. Tsai-Te (Shawn) Lu, Professor, National Tsing Hua University, Taiwan |
|
15:15-15:30 |
Coffee Break |
|
Session 419: Pharmacovigilance, Drug Safety and Risk Management |
|
|
Day 3: Afternoon, July. 17, 2022 |
|
|
Chair |
Dr. Tara A. Nealey, Shareholder, Polsinelli, USA |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Keynote Speech Title: Benefit–risk Evaluation: The past, Present and Future Dr. Juhaeri JUHAERI, Vice President and Head, Epidemiology and Benefit-Risk Evaluation, Sanofi, USA |
|
14:00-14:25 |
Title: TBD Dr. Stefan J. Platz, Senior Vice President, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, UK |
|
14:25-14:50 |
Title: Patenting Drug Delivery Technologies Across the Globe Dr. Tara A. Nealey, Shareholder, Polsinelli, USA |
|
14:50-15:15 |
Title: TBD Dr. Mircea Ciuca, Head, Medical Clinical Drug Safety, Vifor Pharma, Switzerland |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:55 |
Title: Recent Developments in US IP Law Relating to the Protection and Commercialization of Pharmaceuticals Dr. Christopher Griffith, Partner, Green, Griffith Borg-Breen LLP, USA |
|
15:55-16:20 |
Title: Rifampicin-induced Disseminated Intravascular Coagulation: An Antibody-mediated Side Effect Dr. Grimanesa Sousa, Professor, Hospital do Divino Espírito Santo de Ponta Delgada, Portugal |
|
16:20-16:45 |
Speech Opportunity Available Abstract and Biography: Submit Here |
|
16:45-17:10 |
Speech Opportunity Available |
|
Session 424: Cell and Gene Therapy: Translational Development and Clinical Applications |
|
|
Day 3: Afternoon, July. 17, 2022 |
|
|
Chair |
Dr. Anne Tolstrup, Senior Consultant, BioProcess Technology Consultants, Inc., Denmark |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Next Generation of Cell based Therapies for Cancer Dr. Khalid Shah, Associate Professor, Harvard Medical School; Vice Chairman, Department of Neurosurgery, Brigham and Women's Hospital; Principal Faculty, Harvard Stem Cell Institute, Harvard University, USA |
|
14:00-14:25 |
Title: DNA Encoded Affimer Biotherapeutics: A Novel Protein Scaffold that can be Used to Engineer Primary Human Cells Dr. Amrik Basran, CSO, Avacta Life Sciences, UK |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Title: Cell and Gene Therapy: Emerging Manufacturing Options and Challenges Dr. Anne Tolstrup, Senior Consultant, BioProcess Technology Consultants, Inc., Denmark |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:55 |
Title: Current Status and Future Perspectives of Cell and Gene Therapy in Japan Dr. Hiroyuki Fukase, Director, Clinical Research Center, Clinical Research Hospital Tokyo, Japan |
|
15:55-16:20 |
Title: Modulation of RNA Alternative Splicing - A New Therapeutic Frontier Dr. Sebastian Oltean, Associate Professor in Experimental Medicine and Therapeutics, University of Exeter Medical School, UK |
|
16:20-16:45 |
Title: Stem Cells: Best Sources and Antiaging Applications Dr. Marina V. Kovina, Senior Researcher, Institute for Regenerative Medicine, Sechenov University, Russia |
|
16:45-17:10 |
Title: Evoluting Concepts in Stem Cell Therapy: Applications in Neurological Disorders Dr. Hala Gabr, Professor of Hematology, Faculty of Medicine, Cairo University, Egypt |
|
Session 432: Natural Products for Major Diseases |
|
|
Day 3: Afternoon, July. 17, 2022 |
|
|
Chair |
Dr. Alessandro Di Cerbo, Researcher, University of Camerino, Italy |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Traditional Medicine Inspired Drug Discovery - Metabolic Approach Dr. Pulok K. Mukherjee, Director, Institute of Bioresources and Sustainable Development; Professor, Department of Pharmaceutical Technology, Jadavpur University, India |
|
14:00-14:25 |
Title: Can We Use Natural Products to Delay Human Aging? Dr. Brian K Kennedy, Distinguished Professor, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore |
|
14:25-14:50 |
Title: Comparing the Response of Narrowband UVB Therapy to Heliotherapy and a Topical Application of Lecithin and the Amino Acid L Tryptophan Dr. Rowley Noakes, Dermatologist, Queensland Institute of Dermatology, Greenslopes Private Hospital Campus, Greenslopes, QLD, Australia |
|
14:50-15:15 |
Title: Reclaiming African Indigenous Medicine and Iits Associated Value Dr. Mandla S Makhanya, Professor, University of South Africa, South Africa |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:55 |
Speech Opportunity Available |
|
15:55-16:20 |
Speech Opportunity Available |
|
16:20-16:45 |
Speech Opportunity Available |
|
Session 444: Pharma Policy, Regulations and Marketing Trends |
|
|
Day 3: Afternoon, July. 17, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Title: New Pharmaceutical Product Development Progress and Challenges during COVID 19 Dr. Ewa Kleczyk, Vice President of Healthcare Analytics, Symphony Health, PRA Health Sciences, USA |
|
14:25-14:50 |
Title: Expedited approval pathways in drug development-where we are now and where to go? Dr. Gajanan Bhat, Vice President, Clinical Science/Biostatistics, Spectrum Pharmaceuticals, USA |
|
14:50-15:15 |
Title: Novel Approaches in Sales and Marketing in the Field of Pharmaceutical Equipment? Dr. Miha Rajh, Chief Executive Officer, Pharsol, Slovenia |
|
15:15-15:30 |
Coffee Break |
|
Stream 5: Young Scientist Forum |
|
|
Day 3: Afternoon, July. 17, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Title: TBD Ms. Lise Vandevivere, Pharmacist, Laboratory of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Ghent University, Belgium |
|
14:25-14:50 |
Title: TBD Ms. Rina Nakamura, Student (Ph. D course)/Researcher, Kochi University/O-Force Co., Ltd., Japan |
|
14:50-15:15 |
Title: Skin: From Protection through Sensing To Prevention Dr. Nsrein Ali, Postdoctoral Researcher, Laboratory of Developmental Biology, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Finland |
|
15:15-15:30 |
Coffee Break |
© 2003-2022 All rights reserved by BITeomics |